Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
National Health Programs | 1 | 2012 | 445 | 0.330 |
Why?
|
Dyslipidemias | 2 | 2012 | 849 | 0.310 |
Why?
|
Glioblastoma | 6 | 2018 | 3481 | 0.300 |
Why?
|
Lipids | 3 | 2012 | 3305 | 0.280 |
Why?
|
Health Surveys | 1 | 2012 | 4037 | 0.210 |
Why?
|
Brain Neoplasms | 6 | 2018 | 8863 | 0.200 |
Why?
|
Iran | 6 | 2012 | 708 | 0.190 |
Why?
|
Dexamethasone | 2 | 2018 | 1951 | 0.190 |
Why?
|
Area Under Curve | 2 | 2015 | 1654 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.090 |
Why?
|
Obesity, Abdominal | 1 | 2012 | 361 | 0.080 |
Why?
|
ROC Curve | 2 | 2015 | 3527 | 0.080 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1524 | 0.080 |
Why?
|
Reference Values | 2 | 2012 | 4982 | 0.080 |
Why?
|
Cell Movement | 1 | 2017 | 5217 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2737 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8428 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1504 | 0.060 |
Why?
|
Proportional Hazards Models | 6 | 2016 | 12354 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2012 | 11725 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.050 |
Why?
|
Educational Status | 1 | 2010 | 2540 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9849 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2010 | 1359 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.050 |
Why?
|
Prevalence | 3 | 2012 | 15226 | 0.050 |
Why?
|
Cardiovascular Diseases | 3 | 2012 | 15165 | 0.050 |
Why?
|
Prognosis | 6 | 2017 | 29063 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5720 | 0.050 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1376 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.040 |
Why?
|
Survival Analysis | 3 | 2017 | 10252 | 0.040 |
Why?
|
Heart Diseases | 1 | 2011 | 2788 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13408 | 0.040 |
Why?
|
Waist Circumference | 2 | 2012 | 917 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6895 | 0.030 |
Why?
|
Prospective Studies | 4 | 2012 | 53288 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6538 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2017 | 551 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 2010 | 1814 | 0.030 |
Why?
|
Male | 11 | 2017 | 350118 | 0.030 |
Why?
|
Young Adult | 3 | 2016 | 56430 | 0.030 |
Why?
|
Aged | 9 | 2017 | 163280 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2016 | 3327 | 0.030 |
Why?
|
Middle Aged | 10 | 2017 | 213383 | 0.030 |
Why?
|
Female | 11 | 2017 | 380194 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2012 | 235 | 0.030 |
Why?
|
Cholesterol | 2 | 2010 | 2917 | 0.020 |
Why?
|
Adolescent | 3 | 2016 | 85781 | 0.020 |
Why?
|
Pulse | 1 | 2011 | 229 | 0.020 |
Why?
|
Adult | 9 | 2017 | 214055 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5751 | 0.020 |
Why?
|
Hypertension | 1 | 2011 | 8480 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16689 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 517 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Risk Factors | 6 | 2012 | 72290 | 0.020 |
Why?
|
Humans | 13 | 2018 | 744343 | 0.020 |
Why?
|
Body Mass Index | 3 | 2012 | 12720 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5179 | 0.020 |
Why?
|
Systole | 1 | 2011 | 958 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 791 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2011 | 551 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14722 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 634 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39050 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57776 | 0.020 |
Why?
|
Sex Factors | 2 | 2011 | 10397 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
Mice | 3 | 2018 | 81183 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15076 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1184 | 0.020 |
Why?
|
Cohort Studies | 3 | 2015 | 40561 | 0.020 |
Why?
|
Propensity Score | 1 | 2011 | 1781 | 0.020 |
Why?
|
Stem Cells | 1 | 2017 | 3567 | 0.010 |
Why?
|
Triglycerides | 1 | 2010 | 2454 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9438 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.010 |
Why?
|
Animals | 3 | 2018 | 168757 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2356 | 0.010 |
Why?
|
Risk Assessment | 2 | 2012 | 23338 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40075 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8340 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9239 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2017 | 77449 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12788 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8554 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.010 |
Why?
|
Smoking | 1 | 2010 | 8987 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 63114 | 0.010 |
Why?
|
Brain | 1 | 2017 | 26385 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13881 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_